Connect with us


Oxford begins first-of-its-kind trial study to reinfect recovered Coronavirus patients – Republic TV

Oxford to begin its first study of reinfecting recovered patients with the virus. Researchers are looking for 64 healthy, previously Covid-infected volunteers



Article feature image

As Oxford begins its first-of-its-kind trial study that may help to shed light on how to develop a more effective vaccine against the Coronavirus infection, people who have fought off with the COVID-19 virus will be deliberately reinfected. The UK University on Monday said that the researchers are looking for 64 healthy, previously COVID-19 infected volunteers from 18 to 30 years of age to be studied under controlled, quarantine conditions for at least 17 days. Participants will be infected with…

Click here to view the original article.

Continue Reading

You might also like ...

Vaccine hesitancy narrative fuelling divisions in Bolton, says MP – The Guardian
Article feature image
‘Morale is very low’: NHS staff fear ongoing Covid disruption – The Guardian